Cargando…

Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant

BACKGROUND: This study reports our experience in the treatment of aggressive pelvic GCT through wide resection assisted with patient-specific bone-cutting guides (PSBCGs) and subsequent reconstruction with 3D-printed personalized implants (3DPIs), aiming to present the operative technique of this me...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhuangzhuang, Lu, Minxun, Min, Li, Luo, Yi, Tu, Chongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472683/
https://www.ncbi.nlm.nih.gov/pubmed/37658436
http://dx.doi.org/10.1186/s13018-023-04142-4
_version_ 1785100132845355008
author Li, Zhuangzhuang
Lu, Minxun
Min, Li
Luo, Yi
Tu, Chongqi
author_facet Li, Zhuangzhuang
Lu, Minxun
Min, Li
Luo, Yi
Tu, Chongqi
author_sort Li, Zhuangzhuang
collection PubMed
description BACKGROUND: This study reports our experience in the treatment of aggressive pelvic GCT through wide resection assisted with patient-specific bone-cutting guides (PSBCGs) and subsequent reconstruction with 3D-printed personalized implants (3DPIs), aiming to present the operative technique of this method and evaluate its clinical efficacy. METHODS: We retrospectively analyzed seven patients who underwent wide resection of pelvic GCT followed by reconstruction with 3DPIs from August 2019 to February 2021. There were two males and five females, with a mean age of 43 years. PSBCGs and 3DPIs were prepared using 3D-printing technology. The operational outcomes, local recurrence, radiological results, and any associated complications of this technique were assessed. And the functional outcomes were assessed according to the Musculoskeletal Tumor Society (MSTS) 93 functional score. RESULTS: The mean follow-up time was 35.3 months (range 28–45 months). There was no intraoperative complication. Negative surgical margins were achieved in all patients. Postoperative pelvic radiographs showed that 3DPIs matched the shape and size of the bone defect. The anterior–posterior, inlet, and outlet pelvic radiograph demonstrated precise reconstruction consistent with the surgical planning. In addition, tomosynthesis‐Shimadzu metal artifact reduction technology (T-SMART) showed good osseointegration at an average of three months after surgery (range 2–4 months). There was no local recurrence or tumor metastasis. The average MSTS score was 24.4 (range 23–27) at the last follow-up. Delayed wound healing was observed in one patient, and the wounds healed after debridement. Prosthesis-related complications were not detected during the follow-up, such as aseptic loosening or structure failure. CONCLUSIONS: The treatment of aggressive pelvic GCTs through wide resection assisted with PSBCGs and subsequent reconstruction with 3DPIs is a feasible method, which provides good clinical results and reasonable functional outcomes.
format Online
Article
Text
id pubmed-10472683
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104726832023-09-02 Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant Li, Zhuangzhuang Lu, Minxun Min, Li Luo, Yi Tu, Chongqi J Orthop Surg Res Research Article BACKGROUND: This study reports our experience in the treatment of aggressive pelvic GCT through wide resection assisted with patient-specific bone-cutting guides (PSBCGs) and subsequent reconstruction with 3D-printed personalized implants (3DPIs), aiming to present the operative technique of this method and evaluate its clinical efficacy. METHODS: We retrospectively analyzed seven patients who underwent wide resection of pelvic GCT followed by reconstruction with 3DPIs from August 2019 to February 2021. There were two males and five females, with a mean age of 43 years. PSBCGs and 3DPIs were prepared using 3D-printing technology. The operational outcomes, local recurrence, radiological results, and any associated complications of this technique were assessed. And the functional outcomes were assessed according to the Musculoskeletal Tumor Society (MSTS) 93 functional score. RESULTS: The mean follow-up time was 35.3 months (range 28–45 months). There was no intraoperative complication. Negative surgical margins were achieved in all patients. Postoperative pelvic radiographs showed that 3DPIs matched the shape and size of the bone defect. The anterior–posterior, inlet, and outlet pelvic radiograph demonstrated precise reconstruction consistent with the surgical planning. In addition, tomosynthesis‐Shimadzu metal artifact reduction technology (T-SMART) showed good osseointegration at an average of three months after surgery (range 2–4 months). There was no local recurrence or tumor metastasis. The average MSTS score was 24.4 (range 23–27) at the last follow-up. Delayed wound healing was observed in one patient, and the wounds healed after debridement. Prosthesis-related complications were not detected during the follow-up, such as aseptic loosening or structure failure. CONCLUSIONS: The treatment of aggressive pelvic GCTs through wide resection assisted with PSBCGs and subsequent reconstruction with 3DPIs is a feasible method, which provides good clinical results and reasonable functional outcomes. BioMed Central 2023-09-01 /pmc/articles/PMC10472683/ /pubmed/37658436 http://dx.doi.org/10.1186/s13018-023-04142-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Zhuangzhuang
Lu, Minxun
Min, Li
Luo, Yi
Tu, Chongqi
Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title_full Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title_fullStr Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title_full_unstemmed Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title_short Treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3D-printed personalized implant
title_sort treatment of pelvic giant cell tumor by wide resection with patient-specific bone-cutting guide and reconstruction with 3d-printed personalized implant
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472683/
https://www.ncbi.nlm.nih.gov/pubmed/37658436
http://dx.doi.org/10.1186/s13018-023-04142-4
work_keys_str_mv AT lizhuangzhuang treatmentofpelvicgiantcelltumorbywideresectionwithpatientspecificbonecuttingguideandreconstructionwith3dprintedpersonalizedimplant
AT luminxun treatmentofpelvicgiantcelltumorbywideresectionwithpatientspecificbonecuttingguideandreconstructionwith3dprintedpersonalizedimplant
AT minli treatmentofpelvicgiantcelltumorbywideresectionwithpatientspecificbonecuttingguideandreconstructionwith3dprintedpersonalizedimplant
AT luoyi treatmentofpelvicgiantcelltumorbywideresectionwithpatientspecificbonecuttingguideandreconstructionwith3dprintedpersonalizedimplant
AT tuchongqi treatmentofpelvicgiantcelltumorbywideresectionwithpatientspecificbonecuttingguideandreconstructionwith3dprintedpersonalizedimplant